791 related articles for article (PubMed ID: 16770246)
1. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
3. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols.
Ozer K; Izycki D; Zielinski M; Siemionow M
Microsurgery; 2004; 24(3):248-54. PubMed ID: 15160385
[TBL] [Abstract][Full Text] [Related]
4. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
6. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol.
Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R
J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363
[TBL] [Abstract][Full Text] [Related]
7. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
Siemionow MZ; Klimczak A; Unal S
Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients.
Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M
Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324
[TBL] [Abstract][Full Text] [Related]
9. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
11. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
[TBL] [Abstract][Full Text] [Related]
12. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II.
Klimczak A; Agaoglu G; Carnevale KA; Siemionow M
Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y
J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196
[TBL] [Abstract][Full Text] [Related]
14. Induction of tolerance in a rat model of laryngeal transplantation.
Akst LM; Siemionow M; Dan O; Izycki D; Strome M
Transplantation; 2003 Dec; 76(12):1763-70. PubMed ID: 14688529
[TBL] [Abstract][Full Text] [Related]
15. Induction of tolerance in composite-tissue allografts.
Siemionow M; Ortak T; Izycki D; Oke R; Cunningham B; Prajapati R; Zins JE
Transplantation; 2002 Nov; 74(9):1211-7. PubMed ID: 12451256
[TBL] [Abstract][Full Text] [Related]
16. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap.
Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M
Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290
[TBL] [Abstract][Full Text] [Related]
17. [Adenovirus-mediated CTLA4 immunoglobulin based conditioning for non-myeloablative allogeneic hematopoietic cell transplantation to induce tolerance to hind limb allografts in rats].
Pan H; Wang L; Zhang XD; Mai HX; Liu D; Liu Y; Guo SZ
Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(12):937-40. PubMed ID: 19781252
[TBL] [Abstract][Full Text] [Related]
18. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
19. Development and maintenance of donor-specific chimerism in semi-allogenic and fully major histocompatibility complex mismatched facial allograft transplants.
Siemionow M; Demir Y; Mukherjee A; Klimczak A
Transplantation; 2005 Mar; 79(5):558-67. PubMed ID: 15753845
[TBL] [Abstract][Full Text] [Related]
20. Donor cell engraftment in recipient lymphoid tissues after rat limb allograft.
Muramatsu K; Kurokawa Y; Ihara K; You-Xin S; Kawai S
J Surg Res; 2005 Mar; 124(1):38-44. PubMed ID: 15734477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]